Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2888782rdf:typepubmed:Citationlld:pubmed
pubmed-article:2888782lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2888782lifeskim:mentionsumls-concept:C0036536lld:lifeskim
pubmed-article:2888782lifeskim:mentionsumls-concept:C0036537lld:lifeskim
pubmed-article:2888782lifeskim:mentionsumls-concept:C0032005lld:lifeskim
pubmed-article:2888782lifeskim:mentionsumls-concept:C0028778lld:lifeskim
pubmed-article:2888782lifeskim:mentionsumls-concept:C0037663lld:lifeskim
pubmed-article:2888782lifeskim:mentionsumls-concept:C0015688lld:lifeskim
pubmed-article:2888782lifeskim:mentionsumls-concept:C1283071lld:lifeskim
pubmed-article:2888782pubmed:issue4lld:pubmed
pubmed-article:2888782pubmed:dateCreated1987-11-2lld:pubmed
pubmed-article:2888782pubmed:abstractTextIncreases in plasma FFA levels inhibit GH responses to a variety of pharmacological and physiological stimuli. To gain further insight into the mechanism by which FFA exert their effect, we studied the plasma GH responses to GHRH-(1-44) (1 microgram/kg, iv) in normal subjects in whom plasma FFA levels were raised by a lipid-heparin infusion (250 mL 10% Intralipid plus 2500 U heparin). Paired tests were performed in 10 normal subjects, with and without lipid-heparin pretreatment. Lipid-heparin infusion from -30 to 120 min increased mean FFA levels from 0.41 +/- 0.03 (+/- SEM) to 3.12 +/- 0.40 mmol/L at 120 min. The mean plasma GH levels after GHRH administration were lower at all times; however, the values were significantly different (P less than 0.05) only at the later times (45, 60, and 90 min). When considered individually, an all or none pattern was observed; 5 subjects had no plasma GH response to GHRH, and 5 had no reduction. To investigate the time relationships between the FFA peak and subsequent GH blockade, a different protocol of paired tests was performed with GHRH with or without a different lipid-heparin infusion protocol. Lipid-heparin was infused from -90 to 0 min, with an additional heparin pulse at -15 min, to obtain a higher and earlier (0 min) FFA increase. FFA increased from 1.06 +/- 0.19 to 11.61 +/- 0.83 mmol/L at zero time. The GHRH-induced GH secretory peak (15.8 +/- 3.5 ng/ml) at 15 min was completely blocked (0.9 +/- 0.2 ng/ml), and the mean plasma GH levels were also lower at 30, 45, and 60 min. To determine whether the FFA-induced blockade of GH secretion was exerted in the pituitary, a series of in vitro studies was conducted using monolayer cultures of rat anterior pituitary glands, with GHRH concentrations of both 10(-10) and 10(-8) M and 10(-5) M forskolin to stimulate GH release. Both caprylic and oleic acid inhibited basal GH release and GHRH- or forskolin-induced GH release. PRL release was not altered, nor were toxic actions noted on the cells. In conclusion, FFA are able to block GH secretion directly at the pituitary level.lld:pubmed
pubmed-article:2888782pubmed:languageenglld:pubmed
pubmed-article:2888782pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2888782pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2888782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2888782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2888782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2888782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2888782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2888782pubmed:statusMEDLINElld:pubmed
pubmed-article:2888782pubmed:monthOctlld:pubmed
pubmed-article:2888782pubmed:issn0021-972Xlld:pubmed
pubmed-article:2888782pubmed:authorpubmed-author:SchallyA VAVlld:pubmed
pubmed-article:2888782pubmed:authorpubmed-author:SzokeBBlld:pubmed
pubmed-article:2888782pubmed:authorpubmed-author:ScanlonM FMFlld:pubmed
pubmed-article:2888782pubmed:authorpubmed-author:VillanuevaLLlld:pubmed
pubmed-article:2888782pubmed:authorpubmed-author:DiabAAlld:pubmed
pubmed-article:2888782pubmed:authorpubmed-author:Fernandez-Cru...lld:pubmed
pubmed-article:2888782pubmed:authorpubmed-author:DieguezCClld:pubmed
pubmed-article:2888782pubmed:authorpubmed-author:CabranesJ AJAlld:pubmed
pubmed-article:2888782pubmed:authorpubmed-author:CasanuevaF...lld:pubmed
pubmed-article:2888782pubmed:issnTypePrintlld:pubmed
pubmed-article:2888782pubmed:volume65lld:pubmed
pubmed-article:2888782pubmed:ownerNLMlld:pubmed
pubmed-article:2888782pubmed:authorsCompleteYlld:pubmed
pubmed-article:2888782pubmed:pagination634-42lld:pubmed
pubmed-article:2888782pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2888782pubmed:meshHeadingpubmed-meshheading:2888782-...lld:pubmed
pubmed-article:2888782pubmed:meshHeadingpubmed-meshheading:2888782-...lld:pubmed
pubmed-article:2888782pubmed:meshHeadingpubmed-meshheading:2888782-...lld:pubmed
pubmed-article:2888782pubmed:meshHeadingpubmed-meshheading:2888782-...lld:pubmed
pubmed-article:2888782pubmed:meshHeadingpubmed-meshheading:2888782-...lld:pubmed
pubmed-article:2888782pubmed:meshHeadingpubmed-meshheading:2888782-...lld:pubmed
pubmed-article:2888782pubmed:meshHeadingpubmed-meshheading:2888782-...lld:pubmed
pubmed-article:2888782pubmed:meshHeadingpubmed-meshheading:2888782-...lld:pubmed
pubmed-article:2888782pubmed:meshHeadingpubmed-meshheading:2888782-...lld:pubmed
pubmed-article:2888782pubmed:meshHeadingpubmed-meshheading:2888782-...lld:pubmed
pubmed-article:2888782pubmed:meshHeadingpubmed-meshheading:2888782-...lld:pubmed
pubmed-article:2888782pubmed:meshHeadingpubmed-meshheading:2888782-...lld:pubmed
pubmed-article:2888782pubmed:meshHeadingpubmed-meshheading:2888782-...lld:pubmed
pubmed-article:2888782pubmed:meshHeadingpubmed-meshheading:2888782-...lld:pubmed
pubmed-article:2888782pubmed:meshHeadingpubmed-meshheading:2888782-...lld:pubmed
pubmed-article:2888782pubmed:year1987lld:pubmed
pubmed-article:2888782pubmed:articleTitleFree fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary.lld:pubmed
pubmed-article:2888782pubmed:affiliationDepartment of Internal Medicine, Faculty of Medicine, Compostela University, Madrid, Spain.lld:pubmed
pubmed-article:2888782pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2888782pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2888782lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2888782lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2888782lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2888782lld:pubmed